Home
Healthcare
Healthcare & Pharmaceuticals
Blood Plasma Market Growth Opportunities & Forecast [2031]

Blood Plasma Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Blood Type (Factor VIII, Immunoglobulin, Anti-inhibitor Coagulation Factor, Rh Immunoglobulin, Albumin, Anti-Thrombin, and Factor IX), Application (Immunodeficiency Diseases, Bleeding Disorders, Hemophilia, Genetic Lung Disorders, Liver Conditions, Viral Disease, and Immune Deficiency System), End-user (Academic Institutions, Hospitals, Clinics, and Research Laboratories), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

HC-5159
4.1 Rating
176 Pages

Upcoming
81 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

The global blood plasma market size was, USD 31.38 Bn in 2022 and is estimated to reach USD 98.38 Bn by 2031, expanding at a CAGR of 6.7% during 2023–2031. Rising number of blood disorders and growing awareness about hemophilia are expected to fuel the market.

Light yellow-colored liquid portion of blood, which contains protein and other constituents of whole blood where blood cells are absent is known as blood plasma. Blood plasma possesses more than 100 proteins and plays an important role in exchanging minerals and maintaining blood pressure. Plasma is collected through a process of blood collection.

Blood plasma is widely used as a major ingredient in various types of medical products. It replaces antibodies, body fuels, and clotting factors. Plasma carries potassium and sodium to the muscles, which is the electrolyte. The electrolytes help in contracting muscles and keep the human body hydrated.

Blood plasma maintains the PH of the human body, which improves cell function. It provides a liquid base for blood. Blood plasma contains 92% of water. It takes hormones, nutrients, and proteins to the different parts of the body. Cells excrete their waste into the plasma, which in turn, helps in removing it from the human body.

Plasma donation depends upon the blood type. Type AB plasma, considered a universal plasma, has an immediate transfusion without losing important time determining if the patient’s blood type is compatible. Plasma provides water all over the body parts whenever the body needs it. Plasma supports the blood vessels from collapsing. According to American Red Cross, people donate plasma up to 13 times yearly and every 28 days.

The COVID-19 pandemic propelled the blood plasma market. In August 2020, the Food and Drug Administration (FDA) approved and gave an emergency use authorization (EAU) for supporting the treatment for hospitalized patients with the pandemic.

Blood Plasma Market Dynamics

Major Drivers

Rising number of severe blood disorders such as hemophilia, thalassemia, and other diseases are driving the blood plasma market. Increasing approval rate of blood plasma products for emergency treatment in COVID-19 is driving the market.

Growing number of people donating blood and blood plasma to help others recover from various illnesses, which in turn, is propelling the market. Increasing use of blood plasma to treat disorders such as leukemia, types of lymphoma, hemophilia, and malignancies is projected to drive the market. Moreover, high usage of albumin in therapeutic areas and the increasing geriatric population and geriatric medicine are boosting the blood plasma market.

Existing Restraints

High prices of blood plasma treatments and the spread of other pathogenic containments hinder the market. Awareness about the rare side effects such as citrate reaction is projected to hamper the market.

Government restrictions on plasma donation can restrain the market. For instance, the weight of a plasma donor needs to be 110 pounds or 50 kilograms. Plasma donors must pass a medical exam. Thus impeding the market.

Emerging Opportunities

Technology advancement in blood plasma collection and plasma process, and rising demand for plasma therapies due to the ageing population is a major opportunity for blood plasma market investors and healthcare companies. Increasing demand for advanced blood plasma products creates a lucrative opportunity for market players during the forecast period. Moreover, rising clinical studies for the safety and efficacy of a vast range of therapeutic drugs positively is expected to boost the market.

PID is a condition where the human body’s immune system does not function correctly, making humans more susceptible to infections. Blood plasma therapy is used to help patients with PID by providing antibodies to fight off infectious. Increasing R&D activities to develop advanced-level plasma-derived products is projected to create lucrative opportunities in the global blood plasma market.

Scope of Blood Plasma Market Report

The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Blood Plasma Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Blood Type (Factor VIII, Immunoglobulin, Anti-inhibitor Coagulation Factor, Rh Immunoglobulin, Albumin, Anti-Thrombin, and Factor IX), Application (Immunodeficiency Diseases, Bleeding Disorders, Hemophilia, Genetic Lung Disorders, Liver Conditions, Viral Disease, and Immune Deficiency System), and End-user (Academic Institutions, Hospitals, Clinics, and Research Laboratories)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
Key Players Covered in the Report	Pfizer Inc; AbbVie Inc; ADMA Biologics ,inc; Revance; USWM, LLC; Ipsen Pharma; Evolus;Merz Pharma; Merz Pharma; GlaxoSmithKline plc; Biotest AG; and HUGEL, Inc

Blood Plasma Market Segment Insights

Based on blood type, the blood plasma market is divided into factor viii, immunoglobulin, anti-inhibitor coagulation factor, rh immunoglobulin, albumin, anti-thrombin, and factor ix. The immunoglobulin segment is expected to expand at a significant pace during the projection period. Immunoglobin is also called as antibodies, which help recover from blood disorders. Immunoglobin is used as an antibody across the globe, which in turn, drives the segment.

On the basis of application, the global market is segregated into immunodeficiency diseases, bleeding disorders, hemophilia, genetic lung disorders, liver conditions, viral diseases, and immune deficiency system. The hemophilia segment is projected to expand at a considerable CAGR during the forecast period. Increase in research & development activities on hemophilia for the recovery of early stages patients drives the segment.

In terms of end-user, the blood plasma market is categorized as academic institutions, hospitals, clinics, and research laboratories. The hospitals segment is expected to register a robust pace during the forecast period. Convalescent plasma therapy is rapidly used in hospitals for rapid recovery of patients.

Based on region, the global blood plasma market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is projected to dominate the market during the projection period due to the increasing geriatric population, high disposable income, and rising development in biomedical technologies. Additionally, presence of a well-established healthcare sector and rapid adoption of technology in North America are fueling the market in the region. The market in Europe is projected to expand rapidly due to the increasing focus on R&D.

Segments

The global blood plasma market has been segmented on the basis of

Blood Type

Factor VIII
Immunoglobulin
Anti-inhibitor Coagulation Factor
Rh Immunoglobulin
Albumin
Anti-Thrombin
Factor IX

Application

Immunodeficiency Diseases
Bleeding Disorders
Hemophilia
Genetic Lung Disorders
Liver Conditions
Viral Disease
Immune Deficiency System

End-user

Academic Institutions
Hospitals
Clinics
Research Laboratories

Region

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Pfizer Inc
AbbVie Inc
ADMA Biologics, Inc
Revance
USWM, LLC
Ipsen Pharma
Evolus
Merz Pharma
GlaxoSmithKline plc
Biotest AG
HUGEL, Inc

Competitive Landscape

Key players competing in the global blood plasma market Pfizer Inc; AbbVie Inc; ADMA Biologics inc; Revance; USWM, LLC; Ipsen Pharma; Evolus; Merz Pharma; GlaxoSmithKline plc; Biotest AG; and HUGEL, Inc. These players adopt various strategies including product launches, acquisitions, collaboration, mergers, and partnerships to increase their market share.

In March 2019, Biotest AG acknowledged the approval for the abridged solvent volume by half for the Factor VIII concentrate haemoctinR SDH in thirteen countries in Europe.
In January 2020, ADMA Biologics entered to sell and produce a plasma-derived transitional factor in supply and manufacture.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Plasma Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Blood Plasma Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Blood Plasma Market - Supply Chain
  4.5. Global Blood Plasma Market Forecast
     4.5.1. Blood Plasma Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Blood Plasma Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Blood Plasma Market Absolute $ Opportunity
5. Global Blood Plasma Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Blood Plasma Market Size and Volume Forecast by Applications
     5.3.1. Immunodeficiency Diseases
     5.3.2. Bleeding Disorders
     5.3.3. Hemophilia
     5.3.4. Genetic Lung Disorders
     5.3.5. Liver Conditions
     5.3.6. Viral Disease
     5.3.7. Immune Deficiency System
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Blood Plasma Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Blood Plasma Market Size and Volume Forecast by End Users
     6.3.1. Academic Institutions
     6.3.2. Hospitals
     6.3.3. Clinics
     6.3.4. Research Laboratories
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Blood Plasma Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Blood Plasma Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Blood Plasma Demand Share Forecast, 2019-2026
8. North America Blood Plasma Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Blood Plasma Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Blood Plasma Market Size and Volume Forecast by Applications
     8.4.1. Immunodeficiency Diseases
     8.4.2. Bleeding Disorders
     8.4.3. Hemophilia
     8.4.4. Genetic Lung Disorders
     8.4.5. Liver Conditions
     8.4.6. Viral Disease
     8.4.7. Immune Deficiency System
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Blood Plasma Market Size and Volume Forecast by End Users
     8.7.1. Academic Institutions
     8.7.2. Hospitals
     8.7.3. Clinics
     8.7.4. Research Laboratories
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Blood Plasma Demand Share Forecast, 2019-2026
9. Latin America Blood Plasma Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Blood Plasma Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Blood Plasma Market Size and Volume Forecast by Applications
     9.4.1. Immunodeficiency Diseases
     9.4.2. Bleeding Disorders
     9.4.3. Hemophilia
     9.4.4. Genetic Lung Disorders
     9.4.5. Liver Conditions
     9.4.6. Viral Disease
     9.4.7. Immune Deficiency System
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Blood Plasma Market Size and Volume Forecast by End Users
     9.7.1. Academic Institutions
     9.7.2. Hospitals
     9.7.3. Clinics
     9.7.4. Research Laboratories
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Blood Plasma Demand Share Forecast, 2019-2026
10. Europe Blood Plasma Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Blood Plasma Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Blood Plasma Market Size and Volume Forecast by Applications
     10.4.1. Immunodeficiency Diseases
     10.4.2. Bleeding Disorders
     10.4.3. Hemophilia
     10.4.4. Genetic Lung Disorders
     10.4.5. Liver Conditions
     10.4.6. Viral Disease
     10.4.7. Immune Deficiency System
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Blood Plasma Market Size and Volume Forecast by End Users
     10.7.1. Academic Institutions
     10.7.2. Hospitals
     10.7.3. Clinics
     10.7.4. Research Laboratories
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Blood Plasma Demand Share Forecast, 2019-2026
11. Asia Pacific Blood Plasma Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Blood Plasma Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Blood Plasma Market Size and Volume Forecast by Applications
     11.4.1. Immunodeficiency Diseases
     11.4.2. Bleeding Disorders
     11.4.3. Hemophilia
     11.4.4. Genetic Lung Disorders
     11.4.5. Liver Conditions
     11.4.6. Viral Disease
     11.4.7. Immune Deficiency System
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Blood Plasma Market Size and Volume Forecast by End Users
     11.7.1. Academic Institutions
     11.7.2. Hospitals
     11.7.3. Clinics
     11.7.4. Research Laboratories
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Blood Plasma Demand Share Forecast, 2019-2026
12. Middle East & Africa Blood Plasma Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Blood Plasma Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Blood Plasma Market Size and Volume Forecast by Applications
     12.4.1. Immunodeficiency Diseases
     12.4.2. Bleeding Disorders
     12.4.3. Hemophilia
     12.4.4. Genetic Lung Disorders
     12.4.5. Liver Conditions
     12.4.6. Viral Disease
     12.4.7. Immune Deficiency System
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Blood Plasma Market Size and Volume Forecast by End Users
     12.7.1. Academic Institutions
     12.7.2. Hospitals
     12.7.3. Clinics
     12.7.4. Research Laboratories
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Blood Plasma Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Blood Plasma Market: Market Share Analysis
  13.2. Blood Plasma Distributors and Customers
  13.3. Blood Plasma Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Pfizer Inc
     13.4.2. AbbVie Inc
     13.4.3. ADMA Biologics, Inc
     13.4.4. Revance
     13.4.5. USWM, LLC
     13.4.6. Ipsen Pharma
     13.4.7. Evolus
     13.4.8. Merz Pharma
     13.4.9. GlaxoSmithKline plc
     13.4.10. Biotest AG
     13.4.11. HUGEL, Inc

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By